Autophagy is a dynamic and highly regulated process of self-digestion responsible for cell survival and reaction to oxidative stress. As oxidative stress is increased in uremia and is associated with vascular calcification, we studied the role of autophagy in vascular calcification induced by phosphate. In an in vitro phosphate-induced calcification model of vascular smooth muscle cells (VSMCs) and in an in vivo model of chronic renal failure, autophagy was inhibited by the superoxide dismutase mimic MnTMPyP, superoxide dismutase-2 overexpression, and by knockdown of the sodium-dependent phosphate cotransporter Pit1. Although phosphate-induced VSMC apoptosis was reduced by an inhibitor of autophagy (3-methyladenine) and knockdown of autophagy protein 5, calcium deposition in VSMCs was increased during inhibition of autophagy, even with the apoptosis inhibitor Z-VAD-FMK. An inducer of autophagy, valproic acid, decreased calcification. Furthermore, 3-methyladenine significantly promoted phosphate-induced matrix vesicle release with increased alkaline phosphatase activity. Thus, autophagy may be an endogenous protective mechanism counteracting phosphate-induced vascular calcification by reducing matrix vesicle release. Therapeutic agents influencing the autophagic response may be of benefit to treat aging or disease-related vascular calcification and osteoporosis.
Autophagy is a dynamic and highly regulated process of self-digestion responsible for cell survival and reaction to oxidative stress. As oxidative stress is increased in uremia and is associated with vascular calcification, we studied the role of autophagy in vascular calcification induced by phosphate. In an in vitro phosphate-induced calcification model of vascular smooth muscle cells (VSMCs) and in an in vivo model of chronic renal failure, autophagy was inhibited by the superoxide dismutase mimic MnTMPyP, superoxide dismutase-2 overexpression, and by knockdown of the sodium-dependent phosphate cotransporter Pit1. Although phosphate-induced VSMC apoptosis was reduced by an inhibitor of autophagy (3-methyladenine) and knockdown of autophagy protein 5, calcium deposition in VSMCs was increased during inhibition of autophagy, even with the apoptosis inhibitor Z-VAD-FMK. An inducer of autophagy, valproic acid, decreased calcification. Furthermore, 3-methyladenine significantly promoted phosphate-induced matrix vesicle release with increased alkaline phosphatase activity. Thus, autophagy may be an endogenous protective mechanism counteracting phosphate-induced vascular calcification by reducing matrix vesicle release. Therapeutic agents influencing the autophagic response may be of benefit to treat aging or disease-related vascular calcification and osteoporosis.
Macroautophagy (hereafter referred to as autophagy) is a dynamic and highly regulated process of self-digestion. It is a highly conserved cellular process responsible for removal or recycling of long-lived proteins and organelles, and provides cells with an alternative source of nutrients from the reuse of cellular proteins and organelles. 1, 2 This lysosomal degradation pathway is essential for cell survival, differentiation, and development, as well as the cellular response to stress, and thus is associated with neurodegenerative diseases, cancer, heart disease, 3, 4 and arteriosclerosis. 5, 6 Limited autophagy in response to nutrient starvation has a survival function, and specific removal of damaged mitochondria by autophagy can prevent the activation of apoptotic pathways. 7 However, in some systems, induced autophagy can contribute to or enhance the apoptotic response. 8 Vascular calcification is a major risk factor of cardiovascular mortality, particularly in patients with end-stage renal disease. 9 Hyperphosphatemia, manifested during chronic renal failure (CRF) and subsequent dialysis, is highly associated with the extent of vascular calcification and contributes directly to high morbidity and mortality in vascular disease. 10 Phosphate (Pi) level was found to be important in vascular calcification in clinical trials 10 and in vitro 11 and in vivo 12 experimental models. The potential mechanisms mediating Pi-induced matrix calcification of vascular smooth muscle cells (VSMCs) include osteogenic/ chondrogenic conversion, apoptosis, matrix vesicle (MV) release, and matrix remodeling. 13, 14 Recently, we found that a high Pi level induced the production of mitochondrial O 2 Á À and activated NF-kB to induce vascular calcification in both bovine aortic smooth muscle cells (BASMCs) and a rat model of CRF. 15, 16 Many studies have highlighted the important contribution of mitochondrial reactive oxygen species (ROS), especially superoxide (O 2 Á À ), to inducing autophagy. [17] [18] [19] ROSmediated basal autophagy has an important role in maintaining chondrocyte and osteoblast/osteocyte survival and terminal differentiation, as well as regulating bone growth. 20 However, whether autophagy is involved in Pi-induced vascular calcification remains to be elucidated.
Here, we examined the induction of autophagy by Piincreased ROS levels, and the role of autophagy in Pi-induced calcification in VSMCs and a rat model of CRF.
RESULTS

High Pi promotes autophagy in VSMCs
To determine whether autophagy is involved in Pi-induced vascular calcification, we first examined the effect of Pi on autophagosome formation in VSMCs. Pi dose dependently (1.5-3 mmol/l) increased the level of the lipid-conjugated form of the autophagosome marker light-chain 3-II (LC3II) in BASMCs (Figure 1a) . With lysosome-dependent degradation of LC3II blocked by chlorquinol (25 mmol/l), Pi further increased the LC3II level (Figure 1b) . Increased accumulation of LC3 puncta tagged with green fluorescent protein (GFP) indicated Pi induction of autophagosomes (Figure 1c) , and the proportion of cells with GFP-LC3 puncta was sustained from 0.5 to 7 days with Pi treatment (Figure 1d ). Electron microscopy of typical autophagic structures in BASMCs gave direct evidence of the autophagy activation, and increased autophagic structures were observed in cells exposed to Pi for 12 h (Figure 1e ). Increased autophagy was observed in parallel in human aortic VSMCs (HA-VSMCs; Figure 1f and Supplementary Figure S1 online). In addition, immunofluorescence analysis of LC3 puncta revealed autophagosome formation in renal artery walls of a patient with CRF ( Figure 1g ). Thus, high Pi promoted autophagy in both animal and HA-VSMCs.
ROS mediate Pi-induced autophagy in VSMCs
Mitochondrial ROS production contributes to autophagosome formation in many conditions, and the superoxide dismutase mimic MnTMPyP reduces Pi-induced calcification by eliminating mitochondrial ROS. 15 Here, Pi significantly increased mitochondrial ROS level in BASMCs (Figure 2a ). MnTMPyP (25 mmol/l), as well as SOD2 overexpression, significantly decreased Pi-increased LC3II level in BASMCs (Figure 2b and c) . These results were further confirmed by MnTMPyP, decreasing the Pi-increased formation of GFP-LC3 puncta from 47.2 to 20.3% in BASMCs (Figure 2d ). Therefore, ROS generation mediated Pi-induced autophagy in vitro. In addition, MnTMPyP reduced LC3 level ( Figure 2e ) and mitochondrial ROS level (Figure 2f ) in abdominal aortas of CRF rats with high serum Pi level (2.73 ± 0.10 mmol/l in control group vs. 5.50 ± 0.36 mmol/l in CRF group, Po0.05). Indirect immunofluorescence analysis of LC3 puncta in both calcified and non-calcified regions of the aorta (Supplementary Figure S2 online) further showed that MnTMPyP decreased autophagosome formation in the abdominal aortic wall of CRF rats (Figure 2f ).
Type III sodium-dependent Pi cotransporter Pit1 mediates Pi-induced autophagy HA-VSMCs were transfected with scramble small interfering RNA (siRNA) or Pit1 siRNA for 48 h; knockdown of Pit1 expression was confirmed by reverse transcriptase PCR ( Figure 3a ) and western blot analyses (Figure 3b) . Pi increased LC3II level in scramble siRNA-treated HA-VSMCs, and Pit1 knockdown significantly reduced Pi-increased LC3II level (Figure 3c) . Similarly, Pit1 knockdown significantly decreased Pi-induced calcium deposition (Figure 3d ). Therefore, Pit1 mediated Pi-induced autophagy and calcification in VSMCs.
Inhibition of Pi-induced autophagy aggravates calcification
To address the potential role of autophagy in Pi-induced calcification in VSMCs, we first used 3-MA (5 mmol/l), a pharmacological inhibitor of autophagy. 3-MA attenuated the Pi-increased LC3II level (Figure 4a ) and formation of LC3 puncta (43% reduction) (Figure 4b ). To confirm the pharmacological results of 3-MA, siRNA knockdown of autophagy protein 5 (Atg5) expression in rat VSMCs (Figure 4c and Supplementary Figure S3 online) resulted in a significant reduction of LC3 puncta in Pi-treated rat VSMCs (Figure 4d ).
Alizarin red S staining ( Figure 5a ) and calcium content assay ( Figure 5b ) revealed that 3-MA increased calcium deposition in BASMCs pretreated with Pi (3 mmol/l) at 3, 7, and 10 days. Similarly, in HA-VSMCs ( Figure 5c ) and rat VSMCs (Figure 5d ), 3-MA significantly increased Pi-induced calcium deposition. These findings were further confirmed by siRNA knockdown of Atg5, which significantly augmented Pi-induced calcium deposition in both primary rat VSMCs (Figure 5e ) and the rat SMC cell line A7r5 (Figure 5f ). Furthermore, ex vivo experiments of rat aortic rings showed that 3-MA aggravated Pi-induced calcification (Figure 5g ). In contrast, valproic acid (1 mmol/l), a pharmacological inducer of autophagy, significantly ameliorated Pi-induced calcium deposition in both cultured rat aortic rings ( Figure 6a ) and BASMCs ( Figure 6b ). Therefore, autophagy ameliorated Pi-induced vascular calcification.
The pro-calcification effect of autophagy inhibition does not involve ROS-induced apoptosis Autophagy induction under cellular stress may contribute to cell apoptosis or be a mechanism for cell survival, and VSMC apoptosis is one of the mechanisms of Pi-promoted vascular calcification. 21, 22 As expected, Pi increased the activity of apoptosis marker-cleaved caspase-3 ( Figure 7a ) and caspase-3/7 ( Figure 7b ). These increases were reversed by siRNA knockdown of Atg5 and MnTMPyP in rat VSMCs. Consistently, both 3-MA and MnTMPyP reduced the Piincreased apoptosis (indicated by terminal transferase dUTP nick-end labeling staining) (Figure 7c Thus, the pro-calcification effect of autophagy inhibition may not be associated with ROS-induced apoptosis.
Autophagy inhibition increases Pi-induced MV release
MVs were isolated from cell lysates by collagenase digestion. Pi significantly increased MV release, from 0.9 to 5.5 mg, and inhibition of autophagy by 3-MA further promoted Pi-induced MV release, from 5.5 to 9.6 mg, in BASMCs ( Figure 8a ). Annexin II protein content was significantly increased in MVs from calcified BASMCs, and 3-MA further increased the content (Figure 8b ). Furthermore, assay of alkaline phosphatase (ALP) activity as shown by ELF 97 Figure S5a and b online). Thus, the pro-calcification effect of autophagy inhibition may contribute to its promotion of MV release.
DISCUSSION
In this study, we showed that Pi-increased ROS levels potentiated autophagy in cultured VSMCs and aortic walls of a dietary adenine-induced rat CRF model, and the sodium-dependent Pi cotransporter Pit1 mediated the Piinduced autophagy. Inhibition of autophagy by 3-MA or siRNA knockdown of the autophage protein Atg5 significantly aggravated Pi-induced calcium deposition in vitro and ex vivo. However, valproic acid, a pharmacological inducer of autophagy, significantly ameliorated the increased calcification. The underlying mechanisms of the pro-calcification effect of autophagy inhibition involved increased MV release rather than cell apoptosis. Thus, targeting the autophagy pathway may help to prevent or treat vascular calcification in patients with end-stage renal disease.
As autophagy is linked to conditions such as neurodegenerative diseases, cancer, and cardiovascular diseases, it is a prime target for developing therapeutic treatments for these diseases. 23 Evidence of the importance of hyperphosphatemia as a major inducer of vascular calcification comes from studies of genetic syndromes and diseases of renal insufficiency; 13 increased Pi exposure results in the conversion of contractile VSMCs to osteogenic/chondrogenic cells, cell apoptosis, MV release, and matrix remodeling, followed by vascular calcification. 14 Here, we showed that autophagy involved in Pi-induced vascular calcification. Elevated Pi level could induce autophagy, as shown by the formation of GFP-LC3 puncta, increased LC3II level, and electron microscopy of typical autophagic structures in cultured VSMCs and a rat CRF model, as well as the human aortic wall.
Our previous report 15 showed that elevated Pi level could increase the production of mitochondrial ROS, and scavenging intracellular O 2 Á À by MnTMPyP and SOD2 overexpression significantly decreased Pi-induced calcification and autophagy. Thus, increased O 2 Á À level has an important role in Pi-induced autophagy. Chen et al. 17 also showed that O 2 Á À is the major ROS-regulating autophagy. Pit1 was previously found to have an important role in Pi-induced calcification. 24 We also demonstrated that Pit1 was the dominant Pi cotransporter in VSMCs. SiRNA knockdown of Pit1 significantly reduced the Pi-induced calcification and autophagy. Thus, Pit1-mediated Pi transport and ROS generation have a vital role in Pi-induced autophagy. High Pi level may be a new inducer of autophagy, in addition to starvation and H 2 O 2 , which may help in further exploring the mechanisms of Pi-induced vascular diseases.
Autophagy is a multifunctional process involved in various cellular activities 23 and is essential for survival, differentiation and development, as well as the cell response to stress. 2, 25 We wondered whether autophagy functionally contributed to Pi-induced calcification. Autophagy inhibition by both the pharmacological inhibitor 3-MA and siRNA knockdown of Atg5 significantly aggravated Pi-induced calcium deposition in both animal and human aortic cells, including BASMCs, rat VSMCs, HA-VSMCs, and the A7r5 cell line. As expected, the pharmacological autophagy inducer valproic acid had a therapeutic effect on Pi-induced calcification in BASMCs and rat aortic rings. Thus, autophagy may be an endogenous protective mechanism counteracting vascular calcification under hyperphosphatemia. Further research is needed regarding therapeutic agents that influence the autophagic response for treating aging or disease-related vascular calcification.
We wondered how autophagy inhibition augmented Pi-induced calcium deposition. VSMC apoptosis is an important mechanism for Pi-promoted vascular calcification, and drugs that inhibit apoptosis can ameliorate calcification. 21, 22 Autophagy induction under cellular stress may contribute to cell apoptosis or be a mechanism of cell survival. 26 The cytotoxic effects of autophagy may be explained by the direct self-destructive potential of massive autophagy (type II cell death) 27 or by hardwiring the autophagic process to pro-apoptotic signals (type I cell death). 28 In both scenarios, caspase-3 activity is increased. Atg5 has a dual role in autophagy, and apoptosis is regulated by proteolysis of Atg5; thus, siRNA knockdown of Atg5 was found to abolish autophagy and reduce apoptosis. 29 In our study, the Pi-increased caspase-3 activity and terminal transferase dUTP nick-end labeling-positive cells in VSMCs was reversed by the ROS scavenger MnTMPyP. In addition, autophagy inhibition by 3-MA and Atg5 siRNA knockdown reduced the formation of autophagosomes and Pi-increased apoptosis. Finally, autophagy inhibition aggravated Pi-induced calcification even when cell apoptosis was blocked by Z-VAD-FMK. Thus, ROS mediates Pi-induced apoptosis and calcification, but the pro-calcification effect of autophagy inhibition might not involve ROS-mediated VSMC apoptosis.
Thus, an additional mineralization-specific mechanism could be involved in autophagy inhibition-aggravated calcification. Growing evidence suggests that membranebound vesicles from cells are involved in both physiological and pathological calcification. 30 Calcifying membrane-bound vesicles (here, MVs) released from VSMCs participating in VSMC mineralization have been reported in both human SMCs and BASMCs. 31, 32 MVs are membrane-enclosed microstructures released from the cell membrane that have a key role in hydroxyapatite formation and the mineralization process, and the release of ALP into the MV fraction is an important process for MV-mediated mineralization. [30] [31] [32] Recently, 1,25(OH)2D3 was found to stimulate mineralization by increasing MV production. 33 Here, inhibition of autophagy increased Pi-induced MV release and ALP activity, which may be the cause of calcification aggravated by autophagy inhibition. Furthermore, previous works have shown that MV can selectively load ALP in both VSMCs 34 and chondrocytes, and actin polymerization inhibited by cytochalasin D can increase the release of ALP into the MV fraction. 35, 36 In the present study, the ratio of MV ALP to cell ALP indicated increased release of ALP into the MV fraction in 3-MA-treated cells without affecting cellular ALP and osteogenic gene expression, which may indicate that cellular ALP is interrelated with osteogenic differentiation, whereas the release of ALP into the MV fraction involves other mechanisms. The process and mechanism of MV formation and release are not completely understood, but some evidence suggests that the actin cytoskeleton is involved in the release of MVs from chondrocytes/osteoblast-like cells. [36] [37] [38] Despite the absence of direct evidence of the influence of autophagy on the cytoskeleton, cytoskeletal components contribute to the formation of autophagy, 39 and pro-renin receptor knockout can alter the cytoskeleton and lead to the accumulation of LC3-positive vesicles. 40 Our results showed that 3-MA markedly decreased SM-a-actin expression (Supplementary Figure 6a online) . Therefore, we can not exclude the fact that autophagy inhibition may contribute to MV release and load of ALP by regulating the cytoskeleton, which needs further exploration. Several epidemiological studies suggested a relationship between vascular calcification, impaired bone metabolism, and increased mortality, both in patients with chronic kidney disease and the general aging population. [41] [42] [43] Basal autophagy has an important role in maintaining chondrocyte and osteoblast/osteocyte survival and terminal differentiation, as well as in regulating bone growth. 20 With our finding that autophagy is an endogenous protective mechanism counteracting vascular calcification under hyperphosphatemia, therapeutic agents acting on the autophagic response and activities of autophagy-regulating pathways could be developed to treat aging or disease-related vascular calcification and osteoporosis.
MATERIALS AND METHODS Animal protocols
Abdominal aortas were from the CRF rat model fed with 0.75% adenine and 0.9% phosphorus, as we described previously 15 and used for both morphology and western blot analysis. The rat CRF model was confirmed by increased levels of serum creatinine, blood urea nitrogen, and blood Pi in blood samples. MnTmPyP (C 44 Cell culture and cell calcification model BASMCs and rat VSMCs were isolated and cultured as described. [44] [45] [46] Briefly, segments of aortas were obtained from prepubertal bovines and rats. The inner portion of the medium was removed and cut into B1-mm 2 sections, which were placed in a culture dish with Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/l glucose supplemented with 20% fetal bovine serum (FBS) and 10 mmol/l sodium pyruvate. Cells that migrated from the explants were grown in DMEM plus 15% FBS; cells between passages 3 and 8 were used in experiments. T/G HA-VSMCs were from ATCC (Rockville, MD) and cultured in DMEM plus 10% FBS.
For calcification experiments, cells were seeded at a density of 1Â10 4 cells/cm 2 (day 0) and maintained in 15% FBS-DMEM until confluence (day 6), when calcification was induced by adding 10 mmol/L-b-glycerophosphate or 3 mmol/l Pi (Sigma, St Louis, MO). Calcium deposits were detected by measuring calcium content or by alizarin red staining, as we described. 15, 46 For treatment with antioxidants or inhibitors, MnTMPyP (25 mmol/l), Z-VAD-FMK (Promega, Madison, WI, 20 mmol/l), autophagy inhibitor 3-MA (Calbiochem, 5 mmol/l), or chloroquine (Sigma, 25 mmol/l) was added with Pi every 3 days.
Aortic ring calcification
Aortas (from the thoracic to the iliac arteries) were removed in a sterile manner from rats. After the adventitia and endothelium were carefully removed, the vessels were cut into 2-to 3-mm rings and placed in high-Pi (3 mmol/l) or normal culture medium at 37 1C in 5% CO 2 for 7 days, with medium changes every 3 days.
MV isolation
MVs were harvested by following a modified MV isolation protocol. 31, 47 Confluent BASMCs were washed twice with PBS and transferred to control or high-Pi (3 mmol/l) medium for 3 days, and then the medium was decanted after digestion with collagenase and centrifuged at 10,000 g to remove cells and apoptotic bodies. MVs were then harvested from the supernatant by centrifugation at 100,000 g for 30 min at 4 1C in a Hitachi Ultracentrifuge (Hitachinaka, Ibaraki, Japan). MVs were resuspended with 0.1% HCl or 1% Triton X-100, and protein and ALP activity were determined. An increase in protein level indicated an increased number of MVs.
Western blot analysis
Cell and aortic extracts were collected after treatment. The protein underwent sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transfer to a nitrocellulose membrane, which was incubated successively with 3% bovine serum albumin and the primary antibodies anti-LC3 (1:1000, CST, Danvers, MA), anti-cleaved caspase 3 (1:1000, CST), anti-Pit1/2, and anti-b-actin (1:500, both Santa Cruz Biotechnology, Santa Cruz, CA), followed by IRDye700-or 800-conjugated secondary antibody (1:20,000, Rockland, Gilbertsville, PA) for 1 h. Fluorescence signals were detected by the Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE).
Immunofluorescence analysis
Treated samples were fixed with 4% paraformaldehyde and then rendered permeable by incubation in 0.1% Triton X-100 in 5% bovine serum albumin-phosphate-buffered saline for 15 min; the samples were then treated with the antibody anti-LC3, actin, or SM-a-actin (1:200) overnight at 4 1C, followed by treatment with secondary antibody Alexa Fluor R488 donkey anti-rabbit IgG (1:500) for 1 h at 37 1C. Nuclei were labeled with Hoechst 33342. Replacing the primary antibody with normal IgG served as a negative control.
Alizarin red S staining Cells in 6-well plates were washed three times with PBS and fixed with 10% formaldehyde for 10 min. After three washes with PBS, cells were exposed to 1% Alizarin red S for 30 min and washed with 0.2% acetic acid. Positively stained cells showed a reddish/ purple color.
Apoptosis analysis VSMC apoptosis was assessed by measuring caspase 3/7 activity with the use of the Caspase-Glo 3/7 Assay Kit (Promega) and terminal transferase dUTP nick-end labeling assay (Promega). 
Analysis of autophagy by GFP-LC3 redistribution
Electron microscopy
Electron microscopy was performed at our institution's microscopy facility. Briefly, cells were prefixed with 3% glutaraldehyde and postfixed with 2% osmium tetraoxide. After dehydration, cells were embedded in epoxy resin. Ultrathin sections were cut, contrasted with uranyl acetate and lead citrate, and examined under a Zeiss EM-109 electron microscope (Carl Zeiss AG, Carl-Zeiss-Strasse, Oberkochen, Germany).
ALP activity ALP activity was measured colorimetrically as the hydrolysis of p-nitrophenyl Pi with the use of an ALP assay kit (Jiancheng Bioengineering, Nanjing, China). Results were normalized to levels of total protein. Cells or aortic rings were homogenized with 1% Triton X-100 in 0.9% saline on ice and centrifuged in a microfuge at 8000 g for 5 min. The supernatant was removed for ALP and protein concentration assay.
Statistical analysis
Data are reported as mean ± s.e.m. Unpaired Student's t-test was used for analysis of two groups and one-way analysis of variance for three or more groups, followed by Bonferroni's multiple comparison test as applicable by the use of Prism 5. Po0.05 was considered to be statistically significant.
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